FJFu Jianhua

Fu Jianhua

*This is an algorithmically generated author record based on publicly available information.

Fu Jianhua has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gap Junction Protein Expression in Hyperoxia-Exposed Neonatal Rat Lung Tissue

    by Cai Qing, Yu Xuefei, Xue Xindong, Fu Jianhua

    Bronchopulmonary dysplasia (BPD) is a common devastating pulmonary complication in preterm infants. Gap junction is involved in many lung diseases. In this study, we examine the expression of gap junction proteins, including connexin 26 (Cx26), connexin 32 (Cx32), connexin 43 (Cx43), and connexin 46 (Cx46) in neonatal rat lung tissue. Neonatal rats were kept in either 21% (normoxia) or 85% O2(hyperoxia) continuously from postnatal day (PN) 1 to 14. The neonatal rats of normoxia group had well-formed alveoli and a normal RAC value. Distal lung histology in neonatal rats in the hyperoxia group showed fewer and larger alveoli with a lower RAC value (P < 0.01). Compared with the normoxia group, the ROS level and MDA level were significantly higher (P < 0.01), and the GSH level was remarkably lower (P < 0.01) in the hyperoxia group. The statistical analysis of TUNEL staining and apoptosis index (AI) results indicated that AI was significantly higher in the hyperoxia group than in the normoxia group (P < 0.01). Cx26, Cx32, Cx43, and Cx46 mRNAs levels in the hyperoxia group were higher than those in the normoxia group (P < 0.01). Immunohistochemical results suggested that Cx26, Cx32, Cx43, and Cx46 were expressed in the lung tissue of both normoxic and hyperoxic neonatal rats. Immunofluorescence double-staining results suggested that Cx26 was expressed in both alveolar type I (ATI) and alveolar type II (ATII) cells. Nevertheless, its expression was mainly enriched in ATII cells. Cx32 was expressed in ATII cells only. Cx43 was expressed in both ATI and ATII cells. Cx46 was expressed in both ATI and ATII cells, but mainly in ATI cells. The Cx32 mRNA level was positively correlated with ROS level (P < 0.01), positively correlated with AI level (P < 0.01), and negatively correlated with RAC value (P< 0.01). We found that Cx32 was expressed only in ATII cells and was closely related to oxidative stress, apoptosis, and alveolar development. Cx32 may be involved in the development of BPD and may be a novel target for BPD management.

  • Protective Effects of 18β-Glycyrrhetinic Acid on Neonatal Rats with Hyperoxia Exposure

    by Cai Qing, Liu Ziyun, Yu Xuefei, Zhao Xinyi, Xue Xindong, Fu Jianhua

    Bronchopulmonary dysplasia (BPD) is a common devastating pulmonary complication in preterm infants. Supplemental oxygen is a lifesaving therapeutic measure used for premature infants with pulmonary insufficiency. However, oxygen toxicity is a significant trigger for BPD. Oxidative stress disrupts lung development, accompanied by increased pro-inflammatory cytokines and chemokines expression and immune cells infiltration in lung tissue. Licorice, a typical traditional herbal medicine, is commonly used in the medicine and food industries. 18β-Glycyrrhetinic acid (18β-GA), a primary active ingredient of licorice, has powerful anti-oxidative and anti-inflammatory effects. This study aimed to determine whether 18β-GA has a protective effect on neonatal rats with hyperoxia exposure. Newborn Sprague–Dawley rats were kept in either 21% (normoxia) or 80% O2 (hyperoxia) continuously from postnatal day (PN) 1 to 14. 18β-GA was injected intragastrically at 50 or 100 mg/kg body weight once a day from PN 1 to 14. We examined the body weight and alveolar development and measured ROS level and the markers of pulmonary inflammation. Mature-IL-1β and NF-κB pathway proteins, and the NLRP3 inflammasome, were assessed; concurrently, caspase-1 activity was measured. Our results indicated that hyperoxia resulted in alveolar simplification and decreased bodyweight of neonatal rats. Hyperoxia increased ROS level and pulmonary inflammation and activated NF-κB and the NLRP3 inflammasome. 18β-GA treatment inhibited the activation of NF-κB and the NLRP3 inflammasome, decreased ROS level and pulmonary inflammation, improved alveolar development, and increased the bodyweight of neonatal rats with hyperoxia exposure. Our study demonstrates that 18β-GA has a protective effect on neonatal rats with hyperoxia exposure.